InvestorsHub Logo
Followers 18
Posts 6691
Boards Moderated 0
Alias Born 03/06/2010

Re: None

Friday, 06/09/2017 5:30:22 PM

Friday, June 09, 2017 5:30:22 PM

Post# of 402477
Maz - Epic's update on Oxy IR -

Per the Feb 10-Q:

On page 4, but is really like around page 29 after the F pages (financial section). Last sentence is the real update.

"Oxycodone 5mg, Oxycodone 10mg, Oxycodone 15mg, Oxycodone 20mg and Oxycodone 30mg (“Oxy IR”)

We received notification from Epic in October 2015 of the approval by the FDA of Epic’s ANDA for Oxy IR. This product was an Identified IR Product in the Epic Strategic Alliance Agreement Dated March 18, 2009 (the “Epic Strategic Alliance”). Oxy IR was developed at the Northvale Facility pursuant to the Epic Strategic Alliance, in which we are entitled to a Product Fee of 15% of Profits as defined in the Epic Strategic Alliance.

Epic advised us that the first commercial sale of Oxy IR occurred in March 2016 and such sales are ongoing."

Hope that helps.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News